Health & Fitness:Medicine
December 2022 - MHT and ’brain fog’, risks from sodium-containing paracetamol and 2022 revisited
2022-11-22
In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the December 2022 issue of DTB. They discuss cognitive changes that have been reported during the menopause and whether there is a role for MHT (https://dtb.bmj.com/content/60/12/178). They highlight an observational study that found an association between the use of sodium-containing paracetamol and cardiovascular events (https://dtb.bmj.com/content/60/12/181), and talk about the evidence for increasing the dose of vedolizumab in IBD (https://dtb.bmj.com/content/60/12/183). They begin the podcast by talking about their top three highlights from 2022.
The contact address for the DTB team is dtb@bmj.com.
view more
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.
More Episodes
October 2020 - Making medicines safer?
2020-09-28
56
2020-09-28
56
August 2020 - Virtual revolution
2020-07-27
47
2020-07-27
47
Deprescribing in the time of COVID-19
2020-05-27
36
2020-05-27
36
April 2020 - Lung volume in COPD: when less is more
2020-03-24
36
2020-03-24
36
February 2020 - Registering our interest
2020-01-27
34
2020-01-27
34
Melatonin for jet lag
2019-12-20
42
2019-12-20
42
July 2019: It is hard work being a patient
2019-06-19
27
2019-06-19
27
June 2019: If the drugs don’t work
2019-05-29
45
2019-05-29
45
April 2019: DOAC dosing in renal impairment
2019-03-20
39
2019-03-20
39
Get this podcast on your
phone, FREE
